收藏切换
The relationship between the centralized procurement policy for pharmaceuticals and the governance of the Three Medical Reform
收藏切换
Jie HE1, Jianxin HU1, Zhiyou LI1, Bin YUAN2, Liming JIA3, *
World Clinical Drug | 2025, 46(1) : 73 - 80
Less
收藏切换
World Clinical Drug | 2025, 46(1): 73-80
The relationship between the centralized procurement policy for pharmaceuticals and the governance of the Three Medical Reform
Full
Jie HE1, Jianxin HU1, Zhiyou LI1, Bin YUAN2, Liming JIA3, *
Affiliations
  • 1.Department of Pharmacy, Jiangxi Provincial People's Hospital(The First Affiliated Hospital of Nanchang Medical College), Nanchang 330006, Jiangxi Province, China
  • 2.Jiangxi Provincial Medical Pricing and Procurement Service Center, Nanchang 330006, Jiangxi Province, China
  • 3.Jiangxi Provincial Institute of Intelligent Health, Nanchang 330029, Jiangxi Province, China
Published: 2025-01-10 doi: 10.13683/j.wph.2025.01.013
Outline
收藏切换
Objective

To explore the role and existing problems of centralized drug procurement policies in balancing medical, pharmaceutical, and medical insurance costs, ensuring safe and rational use of drugs by the public, and promoting the healthy development of the pharmaceutical industry.

Method

The relevant policies, literature, cases, and data were analyzed, and the impact and response of policies on various stakeholders and their reactions were interpreted from multiple dimensions.

Result

The policy of centralized drug procurement was formed during the period of China's economic marketization reform and medical and health system reform. While promoting the construction of the drug supply guarantee system, the policy has promoted the reform of the compensation mechanism of public hospitals and the medical service prices, promoted the balance of medical insurance funds and the modernization of the medical and health governance system. At present, centralized drug procurement has problems in policy implementation, quality improvement and expansion, slow adjustment of medical service prices, and increased difficulty in balancing the interests of the public, medicine, medical development, and fund security. It is necessary to improve the unified and efficient policy linkage and management coordination mechanism of medical insurance, healthcare, and medicine, and promote "value medicine".

Conclusion

The policy of centralized drug procurement and the reforms related to medicine, healthcare, and medical insurance are mutually causal and synergistic, promoting the modernization process of the governance system and governance capacity of the medicine, healthcare, and medical insurance.

centralized procurement of drugs  /  medical services  /  medical insurance  /  drug supply
何洁, 胡建新, 李志优, 袁斌, 贾立明. 药品集采政策与“三医”改革治理的关系△. 世界临床药物, 2025 , 46 (1) : 73 -80 . DOI: 10.13683/j.wph.2025.01.013
Jie HE, Jianxin HU, Zhiyou LI, Bin YUAN, Liming JIA. The relationship between the centralized procurement policy for pharmaceuticals and the governance of the Three Medical Reform[J]. World Clinical Drug, 2025 , 46 (1) : 73 -80 . DOI: 10.13683/j.wph.2025.01.013
Year 2025 volume 46 Issue 1
51
13
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.01.013
  • Receive Date:2024-10-20
  • Online Date:2026-11-09
  • Published:2025-01-10
Article Data
Affiliations
History
  • Received:2024-10-20
Affiliations
    1.Department of Pharmacy, Jiangxi Provincial People's Hospital(The First Affiliated Hospital of Nanchang Medical College), Nanchang 330006, Jiangxi Province, China
    2.Jiangxi Provincial Medical Pricing and Procurement Service Center, Nanchang 330006, Jiangxi Province, China
    3.Jiangxi Provincial Institute of Intelligent Health, Nanchang 330029, Jiangxi Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.01.013
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT